Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
International Journal of Molecular Sciences
|
June 10, 2022
Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
Daisuke Ikeda, SungGi Chi, Satoshi Uchiyama, et al.
Cureus
|
April 22, 2026
Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study
Nobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
July 9, 2019
[Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration]
Toshiki Terao, Junichiro Yuda, Nobuhiko Yamauchi, et al.
Experimental Hematology
|
May 29, 2012
CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737
Kazuyuki Shimada, Akihiro Tomita, Yosuke Minami, et al.
Journal of Computer Assisted Tomography
|
July 19, 2011
Improved detection of heat stroke-induced brain injury by high b-value diffusion-weighted imaging
Kentaro Kobayashi, Khin Khin Tha, Satoshi Terae, et al.
Journal of Cancer Research and Clinical Oncology
|
January 27, 2023
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors
Ehab Atallah, Michael J Mauro, Andreas Hochhaus, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 8, 2021
[Successful treatment with silver nitrate chemical cauterization for paronychia and granulation in a patient with chronic lymphocytic leukemia undergoing ibrutinib therapy]
Nobue Sato, Junichiro Yuda, Nobuhiko Yamauchi, et al.
Leukemia Research Reports
|
April 29, 2026
FLT3 inhibitor and venetoclax therapy in elderly patients with relapsed/refractory <i>FLT3-ITD</i>+ AML: A report of three cases
Daisuke Ikeda, Satoshi Uchiyama, Yong-Mei Guo, et al.
International Journal of Molecular Sciences
|
March 2, 2017
NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia
Seiji Kakiuchi, Yosuke Minami, Yoshiharu Miyata, et al.
International Journal of Clinical Oncology
|
April 24, 2013
Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia
Takashi Shibata, Yosuke Minami, Ayako Mitsuma, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
International Journal of Molecular Sciences
|
June 10, 2022
Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
Daisuke Ikeda, SungGi Chi, Satoshi Uchiyama, et al.
Cureus
|
April 22, 2026
Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study
Nobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
July 9, 2019
[Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration]
Toshiki Terao, Junichiro Yuda, Nobuhiko Yamauchi, et al.
Experimental Hematology
|
May 29, 2012
CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737
Kazuyuki Shimada, Akihiro Tomita, Yosuke Minami, et al.
Journal of Computer Assisted Tomography
|
July 19, 2011
Improved detection of heat stroke-induced brain injury by high b-value diffusion-weighted imaging
Kentaro Kobayashi, Khin Khin Tha, Satoshi Terae, et al.
Journal of Cancer Research and Clinical Oncology
|
January 27, 2023
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors
Ehab Atallah, Michael J Mauro, Andreas Hochhaus, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 8, 2021
[Successful treatment with silver nitrate chemical cauterization for paronychia and granulation in a patient with chronic lymphocytic leukemia undergoing ibrutinib therapy]
Nobue Sato, Junichiro Yuda, Nobuhiko Yamauchi, et al.
Leukemia Research Reports
|
April 29, 2026
FLT3 inhibitor and venetoclax therapy in elderly patients with relapsed/refractory <i>FLT3-ITD</i>+ AML: A report of three cases
Daisuke Ikeda, Satoshi Uchiyama, Yong-Mei Guo, et al.
International Journal of Molecular Sciences
|
March 2, 2017
NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia
Seiji Kakiuchi, Yosuke Minami, Yoshiharu Miyata, et al.
International Journal of Clinical Oncology
|
April 24, 2013
Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia
Takashi Shibata, Yosuke Minami, Ayako Mitsuma, et al.
Page
of 11